The health system expects over $40 million in net revenue improvement on an annualized basis. Baylor Scott & White Health’s ...
The Food and Drug Administration has approved Novo Nordisk’s once-daily Wegovy pill, the first oral GLP-1 medicine for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback